Search results
Author(s):
Evan A Stein
Added:
1 week ago
ACC.24 — We are joined onsite by investigator, Dr Evan A Stein (Medpace Reference Laboratories, US) to discuss the findings from the LIBerate-CVD trial (NCT04797247).LIBerate-CVD investigated LDL-C reductions in a cohort of 900 patients with cardiovascular diseases and hyper-LDL-cholesterol treated with 300mg subcutaneous Lerodalcibep as compared to placebo across a 52-week treatment period…
View more
Vera Bittner
Research Area(s) / Expertise:
Job title: Professor / Section Head, General Cardiology, Prevention and Imaging
Author
Author(s):
Barbara J Turner
,
Tara Lagu
Added:
3 years ago
Ischemic heart disease and stroke account for nearly 25% of all deaths worldwide.1 With an increasing array of effective medications for hypertension and hyperlipidemia, the toll exacted by vascular disease should diminish. However, control of these two primary causes of vascular disease has been seriously compromised by under-diagnosis and under-treatment.2,3 National survey data in the US has…
View more
Author(s):
Sergio Fazio
Added:
3 years ago
Current Indications for Statin and Fibrate Therapy
The evidence of cardiovascular protection afforded by statins has recently extended beyond patients with hypercholesterolemia. With the publication of several trials,1-7 bold extrapolations of the power of statin therapy in cardiovascular prevention have been offered:
statins equally reduce risk in subjects with or without…
View more
Treating the Common Dyslipidemia in Patients with Type 2 Diabetes—The Effects of Fenofibrate on…
Author(s):
Sergio Fazio
Added:
3 years ago
Article
Author(s):
Peter H Jones
Added:
3 years ago
High Residual Cardiovascular Risk in Diabetic Patients Treated with Statins
According to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII), diabetes is a coronary heart disease (CHD) risk equivalent.1 One major factor contributing to the excess risk of cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) is atherogenic dyslipidemia,…
View more
ACC.24: Late-Breaking Science Video Collection
Video Series
Author(s):
Andrew Choi
,
Jonathan S Steinberg
,
Suneet Mittal
Added:
3 years ago
Atrial fibrillation (AF) is the most frequently observed sustained cardiac arrhythmia encountered in clinical practice. Its incidence is increasing in the US.1 Numerous risk factors have been implicated in the development of AF, including non-modifiable risk factors such as age and gender, modifiable risk factors such as obesity—itself a risk factor for obstructive sleep apnea (OSA)—and smoking,…
View more
Author(s):
Vincent W Dennis
Added:
3 years ago
About 26% of the adult population worldwide has hypertension. In the US adult population, about 30% have hypercholesterolemia and 50–75%, depending on age range, share both. In addition, hypertension and hypercholesterolemia frequently coexist with diabetes, chronic kidney disease, cigarette smoking, obesity and sedentary lifestyle, all of which are potent risk factors for cardiovascular diseases…
View more
Author(s):
Vincent W Dennis
Added:
3 years ago
About 26% of the adult population worldwide has hypertension. In the US adult population, about 30% have hypercholesterolemia and 50-75%, depending on age range, share both. In addition, hypertension and hypercholesterolemia frequently coexist with diabetes, chronic kidney disease, cigarette smoking, obesity and sedentary lifestyle, all of which are potent risk factors for cardiovascular diseases…
View more